Effects of montelukast on M2-related cytokine and chemokine in M2 macrophages
Background/Purpose: Asthma is a chronic airway inflammatory disease mediated by T-helper (Th)2 cells. Montelukast (trade name Singulair) is a cysteinyl leukotriene receptor antagonist used for asthma treatment. Mirroring Th1–Th2 polarization, two distinct states of macrophages have been recognized:...
Main Authors: | Yi-Ching Lin, Ming-Yii Huang, Min-Sheng Lee, Chong-Chao Hsieh, Hsuan-Fu Kuo, Chang-Hung Kuo, Chih-Hsing Hung |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-02-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118216300342 |
Similar Items
-
Macrophages and chemokines as mediators of angiogenesis
by: Jennifer L. Owen, et al.
Published: (2013-07-01) -
Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
by: Li Q, et al.
Published: (2019-12-01) -
Comparison of therapeutic efficacy of antihistaminics and combinations of montelukast with allergic rhinitis
by: Erkan Yildiz, et al.
Published: (2019-12-01) -
Evaluación clínica y funcional en niños asmáticos tratados con montelukast Clinical and functional evaluation in asthmatic children treated with montelukast
by: Concepción Sánchez Infante, et al.
Published: (2011-09-01) -
Asthma in the elderly: a double-blind, placebo-controlled study of the effect of montelukast
by: Michele Columbo
Published: (2017-04-01)